141330-20-3

Basic information

• Product Name: 4H-1-Benzopyran-4-one, 7-(methoxymethoxy)-3-[4-(methoxymethoxy)phenyl]-
• CAS NO: 141330-20-3
• Molecular Formula: C19H18O6
• Molecular Weight: 342.348
• Mol File: 141330-20-3.mol

Chemical Properties

• CAS DataBase Reference: 4H-1-Benzopyran-4-one, 7-(methoxymethoxy)-3-[4-(methoxymethoxy)phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 4H-1-Benzopyran-4-one, 7-(methoxymethoxy)-3-[4-(methoxymethoxy)phenyl]-(141330-20-3)
• EPA Substance Registry System: 4H-1-Benzopyran-4-one, 7-(methoxymethoxy)-3-[4-(methoxymethoxy)phenyl]-(141330-20-3)

Safety Data

• Hazardous Substances Data: 141330-20-3(Hazardous Substances Data)

Upstream product

• 486-66-8 daidzein 
• 107-30-2 chloromethyl methyl ether 
• 124775-22-0 1-<2-Hydroxy-4-(methoxymethoxy)phenyl>-3-<4-(methoxymethoxy)phenyl>prop-2-en-1-on 
• 149-73-5 trimethyl orthoformate 

Downstream Products

• 141330-30-5 (+/-)-2,3-Dihydro-7-(methoxymethoxy)-3-<4-(methoxymethoxy)phenyl>-4H-1-benzopyran-4-on 
• 141330-26-9 (+/-)-cis-3-<2,4-Bis(methoxymethoxy)phenyl>-3,4-dihydro-7-(methoxymethoxy)-2H-1-benzopyran-4-ol 
• 141330-26-9 (+/-)-trans-3-<2,4-Bis(methoxymethoxy)phenyl>-3,4-dihydro-7-(methoxymethoxy)-2H-1-benzopyran-4-ol 
• 141330-24-7 (+/-)-2-<2,4-Bis(methoxymethoxy)phenyl>-1-<2-hydroxy-4-(methoxymethoxy)phenyl>propan-1-on 
• 141330-22-5 (+/-)-3-<2,4-Bis(methoxymethoxy)phenyl>-3,4-dihydro-7-(methoxymethoxy)-2H-1-benzopyran 
• 65332-45-8 (+/-)-4'-O-Demethylvestitol 
• 61135-91-9 (+/-)-9-O-Demethylmedicarpin 
• 79852-13-4 haginin D 
• 17238-05-0 dihydrodaidzein 
• 141330-31-6 (+/-)-3-<2,4-Bis(methoxymethoxy)phenyl>-2,3-dihydro-7-(methoxymethoxy)-4H-1-benzopyran-4-on 
• 141330-32-7 (+/-)-3-<2,4-Bis<(2-methoxyethoxy)methoxy>phenyl>-2,3-dihydro-7-<(2-methoxyethoxy)methoxy>-4H-1-benzopyran-4-on 

Relevant articles and documents

Method for enantioselective hydrogenation of chromenes

A method for preparing an enantiomeric chromane, by asymmetrically hydrogenating a chromene compound in the presence of an Ir catalyst having a chiral ligand. The method includes the enantioselective preparation of enantiomeric equol. A preferred Ir catalyst has a chiral phosphineoxazoline ligand. Enantiomeric chromanes of high stereoselective purity can be obtained.